Catalyst Wire Dossier Catalyst Wire Dossier

Zanamivir (intravenous)

zanamivir · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zanamivir (intravenous), covering 2025-03-17 to 2025-03-17. Get the full timeline:

Most recent: Clinical Trial Update: An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection [Phase 2]

See pricing